Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo E W Lange

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Solid-phase synthesis of thrombin inhibitorsUdo E W Lange, Christian Zechel
Angewandte Chemie (International Ed. in English)|May 2, 2018
Amine Additives Greatly Expand the Scope of Asymmetric Hydrosilylation of IminesXavier Verdaguer, Udo E W Lange, Stephen L Buchwald
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Solid-phase synthesis of endothelin receptor antagonistsUdo E W Lange, Wilfried M Braje, Willi Amberg, et al.
Journal of Chemical Information and Modeling|August 14, 2020
Combining Machine Learning and Molecular Dynamics to Predict P-Glycoprotein SubstratesCarmen Esposito, Shuzhe Wang, Udo E W Lange, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2018
Enzymatic Late-Stage Oxidation of Lead Compounds with Solubilizing Biomimetic Docking/Protecting groupsClare Vickers, Gisela Backfisch, Frank Oellien, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moietyUdo E W Lange, Dorit Baucke, Wilfried Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Orally active thrombin inhibitors. Part 1: optimization of the P1-moietyHelmut Mack, Dorit Baucke, Wilfried Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
Orally active thrombin inhibitors. Part 2: optimization of the P2-moietyUdo E W Lange, Dorit Baucke, Wilfried Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2013
Emerging technologies for metabolite generation and structural diversificationKevin P Cusack, Hannes F Koolman, Udo E W Lange, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Synthesis of highly potent and selective hetaryl ureas as integrin alpha(V)beta3-receptor antagonistsUdo E W Lange, Gisela Backfisch, Jürgen Delzer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Solid-phase synthesis of thrombin inhibitorsUdo E W Lange, Christian Zechel
Angewandte Chemie (International Ed. in English)|May 2, 2018
Amine Additives Greatly Expand the Scope of Asymmetric Hydrosilylation of IminesXavier Verdaguer, Udo E W Lange, Stephen L Buchwald
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Solid-phase synthesis of endothelin receptor antagonistsUdo E W Lange, Wilfried M Braje, Willi Amberg, et al.
Journal of Chemical Information and Modeling|August 14, 2020
Combining Machine Learning and Molecular Dynamics to Predict P-Glycoprotein SubstratesCarmen Esposito, Shuzhe Wang, Udo E W Lange, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2018
Enzymatic Late-Stage Oxidation of Lead Compounds with Solubilizing Biomimetic Docking/Protecting groupsClare Vickers, Gisela Backfisch, Frank Oellien, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moietyUdo E W Lange, Dorit Baucke, Wilfried Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Orally active thrombin inhibitors. Part 1: optimization of the P1-moietyHelmut Mack, Dorit Baucke, Wilfried Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
Orally active thrombin inhibitors. Part 2: optimization of the P2-moietyUdo E W Lange, Dorit Baucke, Wilfried Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2013
Emerging technologies for metabolite generation and structural diversificationKevin P Cusack, Hannes F Koolman, Udo E W Lange, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Synthesis of highly potent and selective hetaryl ureas as integrin alpha(V)beta3-receptor antagonistsUdo E W Lange, Gisela Backfisch, Jürgen Delzer, et al.
Pageof 2